Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Medivolve Inc (MEDV)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Medivolve historical data, for real-time data please try another search
0.030 +0.000    +0.00%
22/02 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.020 / 0.030
  • Day's Range: 0.020 - 0.030
Type:  Equity
Market:  Canada
Medivolve 0.030 +0.000 +0.00%

MEDV Financial Summary

 
A brief financial summary of Medivolve Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Medivolve Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CAD 0.686451 million compared to CAD 1.39 million a year ago. Net loss was CAD 16.46 million compared to CAD 18.37 million a year ago. Basic loss per share from continuing operations was CAD 0.14 compared to CAD 0.54 a year ago. Diluted loss per share from continuing operations was CAD 0.14 compared to CAD 0.54 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MEDV Income Statement

Gross margin TTM 78.26%
Operating margin TTM -32.58%
Net Profit margin TTM -32.98%
Return on Investment TTM 0%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 0.256 0.183 0.194 1.43
Gross Profit 0.137 0.354 0.47
Operating Income -0.541 -1.16 -2.27 -2.53
Net Income -3.51 -1.68 -2.91

MEDV Balance Sheet

Quick Ratio MRQ 0
Current Ratio MRQ 0.08
LT Debt to Equity MRQ 0%
Total Debt to Equity MRQ 0%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 10.33 13.47 14.02
Total Liabilities 18.14 17.64 16.46
Total Equity -7.8 -4.17 -2.44

MEDV Cash Flow Statement

Cash Flow/Share TTM -0.16
Revenue/Share TTM 1.35
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -0.725 0.856 -2.29
Cash From Investing Activities 0.012 -0.246
Cash From Financing Activities -0.019 -0.013 -0.259
Net Change in Cash -0.782 0.597 -2.55
* In Millions of CAD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

MEDV Comments

Write your thoughts about Medivolve Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mayur Patel
Mayur Patel Nov 16, 2021 9:55
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
will be 0.5 soon
Reply
2 3
Report
Emanuel Stackard
Emanuel Stackard Oct 20, 2021 19:09
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this company needs to update what they're doing more often it's really frustrating when it only happens once every 6 months that is not good management
Reply
5 0
Report
jessie hoyt
jessie hoyt Dec 16, 2020 12:03
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Just noticed in the QSC tweet today that the @medivolve twitter account is up and running now.
Reply
1 0
Report
jessie hoyt
jessie hoyt Dec 16, 2020 12:02
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Just noticed in the QSC tweet today that the @medivolve twitter account is up and running now.
Reply
1 0
Report
jessie hoyt
jessie hoyt Dec 11, 2020 17:11
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Doug mentioned a couple of times they are filling a void in the market with respect to what they can offer. There are only 2 rapid antigen tests approved with EUA that don't require instrumentation. One is the abott which The US gov bought a lot of and the other is the one that QSC has. There was an article this morning in the NY Times stating the need for rapid antigen testing and the lack of availability. QSC is getting in touch with the reporter to let them know of QSC and their plans to roll-out testing across the states. As well, Doug mentioned that they are in discussions with other sports teams on testing to bring back the players but as well in some cases the fans. It's clear they are exploring all avenues.
Reply
1 0
Report
jessie hoyt
jessie hoyt Dec 11, 2020 17:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
 The Webinar from yesterday now on YouTube. Just type in questcap Dec 10 Webinar and you'll find it. I'm very pleased with the meeting. Interesting information on the break-even point of 5 tests for each cube. 2-3 days to rollout a new cube when they give the go-ahead at a particular location. 100 cubes by the end of the month will be a crucial milestone to meet. If they can do that, more confidence can be gained on their other projections. The math looks really good. It's all about moving forward on all fronts. If you build it, they will come.
Reply
0 0
Report
MUTHUKUMAR PANCHALINGAM
MUTHUKUMAR PANCHALINGAM May 01, 2020 8:25
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://vancouversun.com/sports/hockey/nhl/patrick-johnston-teams-seeking-serology-test-kits-that-might-help-them-return-to-action/wcm/acb3961f-55dc-4157-a074-2a385d3945b8/?utm_source=mj&utm_medium=push&utm_campaign=mj-push_QSC_audience_VS-LP_audience-Full-CA-DE_cmt_CA-DE_M-F_303102&utm_content=QSC-VS-LP
Reply
0 0
Report
Mike Wolbeck
Mike Wolbeck Apr 29, 2020 10:40
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
any recent info on this stock?
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email